Last 12 months
Inside the activity.
13 purchase rows · 7 sale rows
Disclosed non-derivative P/S rows, by transaction month. Includes amendments and private transactions.Monthly counts
| Month | Purchases | Sales |
|---|---|---|
| Nov 2025 | 4 | 0 |
| Dec 2025 | 0 | 0 |
| Jan 2026 | 0 | 0 |
| Feb 2026 | 0 | 0 |
| Mar 2026 | 3 | 0 |
| Apr 2026 | 0 | 0 |
| May 2026 | 5 | 3 |
| Jun 2026 | 1 | 0 |
| Jul 2026 | 0 | 0 |
| Aug 2026 | 0 | 2 |
| Sep 2026 | 0 | 2 |
| Oct 2026 | 0 | 0 |
Latest available
Insider transactions
Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”
The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.
| Transaction date | Owner / reported role | Activity / security | Shares / units | Reported price | Reported value | Details |
|---|---|---|---|---|---|---|
| August 29, 2023 Filed Jan 12, 2024 22:47 UTC Amendment |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 41,666 | $0.60 | $24,999.60 |
DisclosureSEC source: 0000950170-24-004313 · ownership.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 352,193 F1 · shares: Represents purchase of shares as part of a public offering by the Registrant under Form S-3, which closed on August 29, 2023 Read SEC document |
| August 28, 2023 Filed Aug 30, 2023 20:22 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 42,500 | $0.75 | $31,794.25 |
DisclosureSEC source: 0000950170-23-045447 · ownership.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 792,845 F1 · price: Represents volume weighted average purchase price. Purchases were made in multiple lots at prices ranging from $0.6189 to $0.82 per share. Reporting person agrees to provide details of the transactions to the Commission upon request. Read SEC document |
| August 03, 2023 Filed Aug 3, 2023 21:41 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 125 | $0.71 | $88.75 |
DisclosureSEC source: 0000950170-23-038163 · ownership.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,223 F1 · shares: Represents shares sold on August 3, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on August 2, 2023. Transaction was completed pursuant to an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| July 05, 2023 Filed Jul 5, 2023 20:54 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 109 | $0.60 | $65.40 |
DisclosureSEC source: 0001209191-23-041159 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 141,348 F1 · shares: Represents shares sold on July 5, 2023 solely to pay income taxes resulting from the vesting of restricted stock units on July 2, 2023. Transaction was completed based on an irrevocable election made by the Reporting Person in conjunction with the original grant in November 2020. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:31 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 250,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040330 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 750,345 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 28, 2024. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:36 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040341 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 141,457 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 28, 2024. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:37 UTC |
Mitchell MicahChief Commerical Officer
|
GrantCommon Stock | 80,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040343 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 161,794 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 28, 2024. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 16:26 UTC |
Knapp Amy K.Director
|
GrantCommon Stock | 59,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040323 · doc4.xml · nonDerivative · entry 1 Knapp Amy K. · CIK 0001707416 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 79,611 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2023. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:27 UTC |
Morris Milton MayoDirector
|
GrantCommon Stock | 59,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040324 · doc4.xml · nonDerivative · entry 1 Morris Milton Mayo · CIK 0001454309 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 62,933 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2023. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:23 UTC |
KIRK THOMAS FDirector
|
GrantCommon Stock | 59,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040320 · doc4.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 86,499 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2023. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:33 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 130,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040334 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 310,527 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 28, 2024. Read SEC document |
| June 28, 2023 Filed Jun 30, 2023 20:22 UTC |
Crowley Thomas Aloysius Jr.Director
|
GrantCommon Stock | 59,988 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-040318 · doc4.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 59,988 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units vest in quarterly installments over one year beginning on September 7, 2023. Read SEC document |
| June 09, 2023 Filed Jun 12, 2023 22:10 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 499 | $0.46 | $230.09 |
DisclosureSEC source: 0001209191-23-036463 · doc4.xml · nonDerivative · entry 2 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,328 F1 · shares: Represents shares withheld solely to pay income taxes resulting from vesting of restricted stock units on June 8 and June 9, 2023. Read SEC document |
| June 08, 2023 Filed Jun 12, 2023 22:10 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 5,105 | $0.46 | $2,363.62 |
DisclosureSEC source: 0001209191-23-036463 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 61,827 F1 · shares: Represents shares withheld solely to pay income taxes resulting from vesting of restricted stock units on June 8 and June 9, 2023. Read SEC document |
| June 06, 2023 Filed Jun 6, 2023 20:18 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 125 | $0.55 | $68.75 |
DisclosureSEC source: 0001209191-23-034753 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 66,932 F1 · shares: Represents shares sold on June 6, 2023 solely to pay income taxes resulting from vesting of restricted stock units on June 2, 2023, pursuant to an irrevocable arrangement between the Reporting Person and the Issuer. Read SEC document |
| May 03, 2023 Filed May 3, 2023 21:16 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 131 | $0.55 | $72.05 |
DisclosureSEC source: 0001209191-23-027066 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Plan reported Ownership: Direct Disclosed balance after: 67,057 F1 · shares: Represents shares sold on May 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on May 2, 2023, pursuant to an irrevocable arrangement between the Reporting Person and the Issuer. Read SEC document |
| April 03, 2023 Filed Apr 3, 2023 22:01 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 129 | $0.73 | $94.17 |
DisclosureSEC source: 0001209191-23-022342 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 67,188 F1 · shares: Represents shares sold on April 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on April 2, 2023. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 23:48 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017962 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 500,345 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in their entirety on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 23:53 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017968 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 67,317 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in their entirety on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 23:55 UTC |
Mitchell MicahChief Commerical Officer
|
GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017971 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 81,815 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in their entirety on March 8, 2024. Read SEC document |
| March 08, 2023 Filed Mar 10, 2023 23:51 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 17,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-23-017965 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 180,527 F1 · shares: Represents grant of Restricted Stock Units (RSU's) under the Issuer's 2018 Stock Option and Incentive Plan. These RSU's shall vest in their entirety on March 8, 2024. Read SEC document |
| March 03, 2023 Filed Mar 6, 2023 21:34 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 130 | $0.62 | $80.60 |
DisclosureSEC source: 0001209191-23-016286 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,317 F1 · shares: Represents shares sold on March 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on March 2, 2023. Read SEC document |
| February 03, 2023 Filed Feb 3, 2023 22:07 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 132 | $0.49 | $64.68 |
DisclosureSEC source: 0001209191-23-007024 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,447 F1 · shares: Represents shares sold on February 3, 2023 solely to pay income taxes resulting from vesting of restricted stock units on February 2, 2023. Read SEC document |
| January 17, 2023 Filed Jan 18, 2023 23:59 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
PurchaseCommon Stock | 307,692 | $0.33 | $99,999.90 |
DisclosureSEC source: 0001209191-23-003848 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 483,345 F1 · shares: Represents purchase of common stock as part of the Registrant's equity offering, which was completed on January 17, 2023 Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 00:07 UTC |
Mitchell MicahChief Commerical Officer
|
PurchaseCommon Stock | 15,384 | $0.33 | $4,999.80 |
DisclosureSEC source: 0001209191-23-003862 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 64,815 F1 · shares: Represents purchase of common stock as part of the Registrant's equity offering, which was completed on January 17, 2023 Read SEC document |
| January 17, 2023 Filed Jan 19, 2023 00:02 UTC |
HENRY DAVID AChief Financial Officer
|
PurchaseCommon Stock | 76,923 | $0.33 | $24,999.98 |
DisclosureSEC source: 0001209191-23-003850 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 163,527 F1 · shares: Represents purchase of common stock as part of the Registrant's equity offering, which was completed on January 17, 2023 Read SEC document |
| January 04, 2023 Filed Jan 5, 2023 00:08 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 139 | $0.49 | $68.11 |
DisclosureSEC source: 0001209191-23-001387 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,579 F1 · shares: Represents shares sold on January 4, 2023 solely to pay income taxes resulting from vesting of restricted stock units on January 2, 2023. Read SEC document |
| December 05, 2022 Filed Dec 5, 2022 22:44 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 126 | $0.66 | $83.16 |
DisclosureSEC source: 0001209191-22-059803 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,718 F1 · shares: Represents shares sold on December 5, 2022 solely to pay income taxes resulting from vesting of restricted stock units on December 2, 2022. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:21 UTC |
KIRK THOMAS FDirector
|
OtherWarrants · Derivative | 333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-059765 · doc4.xml · derivative · entry 2 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 333 shares Expires 2022-12-05 F1 · shares: Represents the exercise of warrants issued as part of the Registrant's public equity offering in December 2017. The original exercise price of the warrants was $88.50 per share (as adjusted for stock splits, combinations, recapitalizations and similar adjustments). As a result of the Registrant's equity offering in February 2020, the price protection provision in the warrant reduced the exercise price to the current exercise price of $0.0001. Read SEC document |
| December 01, 2022 Filed Dec 5, 2022 22:21 UTC |
KIRK THOMAS FDirector
|
OtherCommon Stock | 333 | $0.00 | $0.03 |
DisclosureSEC source: 0001209191-22-059765 · doc4.xml · nonDerivative · entry 1 KIRK THOMAS F · CIK 0001258258 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 26,513 F1 · shares: Represents the exercise of warrants issued as part of the Registrant's public equity offering in December 2017. The original exercise price of the warrants was $88.50 per share (as adjusted for stock splits, combinations, recapitalizations and similar adjustments). As a result of the Registrant's equity offering in February 2020, the price protection provision in the warrant reduced the exercise price to the current exercise price of $0.0001. Read SEC document |
| November 22, 2022 Filed Nov 23, 2022 00:33 UTC |
HENRY DAVID AChief Financial Officer
|
PurchaseCommon Stock | 9,000 | $0.55 | $4,959.90 |
DisclosureSEC source: 0001209191-22-058524 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 86,604 F1 · price: Represents weighted average purchase price. Purchases were made in multiple transactions at prices ranging from $0.5499 - $0.556 per share Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 22:17 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
OtherWarrants · Derivative | 333 | $0.00 Strike: $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-058709 · doc4.xml · derivative · entry 2 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 0 Underlying: Common Stock · 333 shares Expires 2022-12-05 F1 · shares: Represents the exercise of warrants issued as part of the Registrant's public equity offering in December 2017. The original exercise price of the warrants was $88.50 per share (as adjusted for stock splits, combinations, recapitalizations and similar adjustments). As a result of the Registrant's equity offering in February 2020, the price protection provision in the warrant reduced the exercise price to the current exercise price of $0.0001. Read SEC document |
| November 21, 2022 Filed Nov 23, 2022 22:17 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
OtherCommon Stock | 333 | $0.00 | $0.03 |
DisclosureSEC source: 0001209191-22-058709 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,653 F1 · shares: Represents the exercise of warrants issued as part of the Registrant's public equity offering in December 2017. The original exercise price of the warrants was $88.50 per share (as adjusted for stock splits, combinations, recapitalizations and similar adjustments). As a result of the Registrant's equity offering in February 2020, the price protection provision in the warrant reduced the exercise price to the current exercise price of $0.0001. Read SEC document |
| November 03, 2022 Filed Nov 4, 2022 21:28 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 125 | $1.37 | $171.25 |
DisclosureSEC source: 0001209191-22-055833 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,844 F1 · shares: Represents shares sold on November 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on November 2, 2022. Read SEC document |
| October 03, 2022 Filed Oct 3, 2022 20:37 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 128 | $1.57 | $200.96 |
DisclosureSEC source: 0001209191-22-051849 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 50,969 F1 · shares: Represents shares sold on October 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on October 2, 2022. Read SEC document |
| September 06, 2022 Filed Sep 6, 2022 20:36 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 128 | $1.76 | $225.28 |
DisclosureSEC source: 0001209191-22-048761 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,097 F1 · shares: Represents shares sold on September 6, 2022 solely to pay income taxes resulting from vesting of restricted stock units on September 2, 2022. Read SEC document |
| August 05, 2022 Filed Aug 8, 2022 21:03 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 7,141 | $1.71 | $12,218.25 |
DisclosureSEC source: 0001209191-22-044837 · doc4.xml · nonDerivative · entry 1 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 12,901 F1 · price: Represents average sales price. Shares were sold at prices ranging from $1.68 - $1.76 per share. Read SEC document |
| August 03, 2022 Filed Aug 4, 2022 20:25 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 118 | $1.91 | $225.55 |
DisclosureSEC source: 0001209191-22-044423 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,225 F1 · shares: Represents shares sold on August 3, 2022 solely to pay income taxes resulting from vesting of restricted stock units on August 2, 2022. Read SEC document |
| July 05, 2022 Filed Jul 5, 2022 20:57 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 127 | $1.64 | $208.28 |
DisclosureSEC source: 0001209191-22-040760 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,343 F1 · shares: Represents shares sold on July 5, 2022 solely to pay income taxes resulting from vesting of restricted stock units on July 2, 2022. Read SEC document |
| June 14, 2022 Filed Jun 30, 2023 20:18 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 291 | $1.67 | $485.39 |
DisclosureSEC source: 0001209191-23-040313 · doc4.xml · nonDerivative · entry 5 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 0 F1 · date: Due to oversight, these reported sale transactions were not reported timely and are being reported at this time. F2 · price: Represents average sales price for the reported transaction. The reporting person undertakes to provide Myomo, Inc., any security holder of Myomo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the average price set forth herein. Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 13:20 UTC |
Kovelman HarryChief Medical Officer
|
Tax withholdingCommon Stock | 484 | $1.83 | $885.72 |
DisclosureSEC source: 0001209191-22-037262 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,470 F1 · shares: Represents shares sold on June 13, 2022 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2022. Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 13:18 UTC |
Mitchell MicahChief Commerical Officer
|
Tax withholdingCommon Stock | 1,846 | $1.79 | $3,311.72 |
DisclosureSEC source: 0001209191-22-037260 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 49,431 F1 · shares: Represents shares sold on June 13, 2022 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2022. F2 · price: Represents weighted average sales price. Sales were made at prices ranging from $1.78 - $1.83 per share Read SEC document |
| June 13, 2022 Filed Jun 16, 2022 13:19 UTC |
HENRY DAVID AChief Financial Officer
|
Tax withholdingCommon Stock | 4,417 | $1.80 | $7,932.93 |
DisclosureSEC source: 0001209191-22-037261 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 77,604 F1 · shares: Represents shares sold on June 13, 2022 solely to pay income taxes resulting from vesting of restricted stock units on June 9, 2022. F2 · price: Represents weighted average sales price. Sales were made at prices ranging from $1.78 - $1.83 per share Read SEC document |
| June 10, 2022 Filed Jun 30, 2023 20:18 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 6,000 | $1.97 | $11,790.00 |
DisclosureSEC source: 0001209191-23-040313 · doc4.xml · nonDerivative · entry 4 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 291 F1 · date: Due to oversight, these reported sale transactions were not reported timely and are being reported at this time. F2 · price: Represents average sales price for the reported transaction. The reporting person undertakes to provide Myomo, Inc., any security holder of Myomo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the average price set forth herein. Read SEC document |
| June 09, 2022 Filed Jun 30, 2023 20:18 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 110 | $2.15 | $236.06 |
DisclosureSEC source: 0001209191-23-040313 · doc4.xml · nonDerivative · entry 3 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,291 F1 · date: Due to oversight, these reported sale transactions were not reported timely and are being reported at this time. F2 · price: Represents average sales price for the reported transaction. The reporting person undertakes to provide Myomo, Inc., any security holder of Myomo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the average price set forth herein. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 00:43 UTC |
GUDONIS PAUL RDirector · Chief Executive Officer
|
GrantCommon Stock | 75,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035673 · doc4.xml · nonDerivative · entry 1 GUDONIS PAUL R · CIK 0001015994 · Director · Chief Executive Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 175,320 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 8, 2023. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:49 UTC |
Kovelman HarryChief Medical Officer
|
GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035945 · doc4.xml · nonDerivative · entry 1 Kovelman Harry · CIK 0001853204 · Chief Medical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,954 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 8, 2023. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:59 UTC |
Mitchell MicahChief Commerical Officer
|
GrantCommon Stock | 28,000 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035965 · doc4.xml · nonDerivative · entry 1 Mitchell Micah · CIK 0001746072 · Chief Commerical Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 51,277 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 8, 2023. Read SEC document |
| June 08, 2022 Filed Jun 10, 2022 20:41 UTC |
HENRY DAVID AChief Financial Officer
|
GrantCommon Stock | 41,500 | $0.00 | $0.00 |
DisclosureSEC source: 0001209191-22-035932 · doc4.xml · nonDerivative · entry 1 HENRY DAVID A · CIK 0001195842 · Chief Financial Officer 10b5-1 filing: Not disclosed Ownership: Direct Disclosed balance after: 82,021 F1 · shares: Represents grant of Restricted Stock Units under the Issuer's 2018 Stock Option and Incentive Plan, each representing a contingent right to receive one share of the Issuer's common stock. Such Restricted Stock Units shall vest in two equal annual installments beginning June 8, 2023. Read SEC document |
| June 08, 2022 Filed Jun 30, 2023 20:18 UTC |
Crowley Thomas Aloysius Jr.Director
|
SaleCommon Stock | 3,000 | $2.15 | $6,441.00 |
DisclosureSEC source: 0001209191-23-040313 · doc4.xml · nonDerivative · entry 2 Crowley Thomas Aloysius Jr. · CIK 0001706753 · Director 10b5-1 filing: No plan indicated Ownership: Direct Disclosed balance after: 6,401 F1 · date: Due to oversight, these reported sale transactions were not reported timely and are being reported at this time. F2 · price: Represents average sales price for the reported transaction. The reporting person undertakes to provide Myomo, Inc., any security holder of Myomo, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the average price set forth herein. Read SEC document |
Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.